مصطلحات الفهرس: renal graft dysfunction/dt [Drug Therapy], cyclosporine/dt [Drug Therapy], DNA/ec [Endogenous Compound], mammalian target of rapamycin/dt [Drug Therapy], mycophenolic acid/dt [Drug Therapy], OKT 3/dt [Drug Therapy], prednisolone/dt [Drug Therapy], tacrolimus/dt [Drug Therapy], adult, antibody mediated rejection, antibody specificity, article, blood sampling, cohort analysis, comparative study, controlled study, creatinine blood level, cross-sectional study, diagnostic test accuracy study, droplet digital polymerase chain reaction, female, genotype, histopathology, human, human tissue, immunosuppressive treatment, kidney allograft, major clinical study, priority journal, prospective study, proteinuria, renal graft dysfunction/di [Diagnosis], male, renal graft dysfunction/pc [Prevention], sensitivity and specificity, azathioprine/dt [Drug Therapy], basiliximab/dt [Drug Therapy], creatinine/ec [Endogenous Compound], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35734Test
American Journal of Transplantation
Click here for full text options
LibKey Link

مصطلحات الفهرس: renal graft dysfunction/dt [Drug Therapy], cyclosporine/dt [Drug Therapy], DNA/ec [Endogenous Compound], mammalian target of rapamycin/dt [Drug Therapy], mycophenolic acid/dt [Drug Therapy], OKT 3/dt [Drug Therapy], prednisolone/dt [Drug Therapy], tacrolimus/dt [Drug Therapy], adult, antibody mediated rejection, antibody specificity, article, blood sampling, cohort analysis, comparative study, controlled study, creatinine blood level, cross-sectional study, diagnostic test accuracy study, droplet digital polymerase chain reaction, female, genotype, histopathology, human, human tissue, immunosuppressive treatment, kidney allograft, major clinical study, priority journal, prospective study, proteinuria, renal graft dysfunction/di [Diagnosis], male, renal graft dysfunction/pc [Prevention], sensitivity and specificity, azathioprine/dt [Drug Therapy], basiliximab/dt [Drug Therapy], creatinine/ec [Endogenous Compound], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35734Test
American Journal of Transplantation
LibKey Link

مصطلحات الفهرس: case report, clinical article, creatinine blood level, disease activity, drug substitution, drug withdrawal, end stage renal disease/su [Surgery], female, graft infection/co [Complication], graft infection/dt [Drug Therapy], graft recipient, graft versus host reaction/pc [Prevention], human, human tissue, kidney biopsy, kidney graft rejection/dt [Drug Therapy], kidney transplantation, leukopenia, lymphocytopenia, microsporidiosis/co [Complication], microsporidiosis/dt [Drug Therapy], middle aged, neutropenia, plasma exchange, priority journal, renal graft dysfunction, rheumatoid arthritis/dt [Drug Therapy], vestibular neuronitis, albendazole/dt [Drug Therapy], tacrolimus/cb [Drug Combination], tacrolimus/dt [Drug Therapy], graft versus host reaction/dt [Drug Therapy], albendazole/po [Oral Drug Administration], basiliximab/cb [Drug Combination], basiliximab/dt [Drug Therapy], creatinine/ec [Endogenous Compound], hydroxychloroquine/dt [Drug Therapy], methotrexate/dt [Drug Therapy], methylprednisolone/dt [Drug Therapy], mycophenolic acid/cb [Drug Combination], mycophenolic acid/dt [Drug Therapy], pantoprazole, prednisolone/cb [Drug Combination], prednisolone/dt [Drug Therapy], ranitidine, salazosulfapyridine/dt [Drug Therapy], adult, article, bone marrow transplantation, Article

URL: Transplant Infectious Disease
Click here for full text options
LibKey Link

مصطلحات الفهرس: case report, clinical article, creatinine blood level, disease activity, drug substitution, drug withdrawal, end stage renal disease/su [Surgery], female, graft infection/co [Complication], graft infection/dt [Drug Therapy], graft recipient, graft versus host reaction/pc [Prevention], human, human tissue, kidney biopsy, kidney graft rejection/dt [Drug Therapy], kidney transplantation, leukopenia, lymphocytopenia, microsporidiosis/co [Complication], microsporidiosis/dt [Drug Therapy], middle aged, neutropenia, plasma exchange, priority journal, renal graft dysfunction, rheumatoid arthritis/dt [Drug Therapy], vestibular neuronitis, albendazole/dt [Drug Therapy], tacrolimus/cb [Drug Combination], tacrolimus/dt [Drug Therapy], graft versus host reaction/dt [Drug Therapy], albendazole/po [Oral Drug Administration], basiliximab/cb [Drug Combination], basiliximab/dt [Drug Therapy], creatinine/ec [Endogenous Compound], hydroxychloroquine/dt [Drug Therapy], methotrexate/dt [Drug Therapy], methylprednisolone/dt [Drug Therapy], mycophenolic acid/cb [Drug Combination], mycophenolic acid/dt [Drug Therapy], pantoprazole, prednisolone/cb [Drug Combination], prednisolone/dt [Drug Therapy], ranitidine, salazosulfapyridine/dt [Drug Therapy], adult, article, bone marrow transplantation, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/37337Test
Transplant Infectious Disease
Click here for full text options
LibKey Link

مصطلحات الفهرس: article, blood transfusion, cross-sectional study, disease association, disease severity, dosage schedule comparison, drug dose reduction, female, gender, graft infection/co [Complication], graft recipient, human, iron deficiency, kidney pancreas transplantation, major clinical study, male, prevalence, proteinuria, risk factor, acetylsalicylic acid/cb [Drug Combination], acetylsalicylic acid/dt [Drug Therapy], anticoagulant agent/dt [Drug Therapy], antithrombocytic agent/cb [Drug Combination], antithrombocytic agent/dt [Drug Therapy], basiliximab/dt [Drug Therapy], clopidogrel/dt [Drug Therapy], cotrimoxazole/do [Drug Dose], cotrimoxazole/dt [Drug Therapy], cyclosporine/dt [Drug Therapy], erythropoietin/dt [Drug Therapy], immunoglobulin G/dt [Drug Therapy], immunoglobulin G/iv [Intravenous Drug Administration], tacrolimus/dt [Drug Therapy], transferrin/ec [Endogenous Compound], valganciclovir/do [Drug Dose], valganciclovir/dt [Drug Therapy], warfarin/dt [Drug Therapy], kidney function, iron/dt [Drug Therapy], iron/iv [Intravenous Drug Administration], iron/po [Oral Drug Administration], mycophenolate mofetil/dt [Drug Therapy], prednisolone/dt [Drug Therapy], proton pump inhibitor/do [Drug Dose], proton pump inhibitor/dt [Drug Therapy], acute graft rejection/di [Diagnosis], acute graft rejection/dt [Drug Therapy], acute graft rejection/th [Therapy], adult, anemia/co [Complication], anemia/di [Diagnosis], anemia/dt [Drug Therapy], anemia/th [Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/36865Test
BMC Nephrology
Click here for full text options
LibKey Link

مصطلحات الفهرس: drug dose reduction, drug substitution, drug withdrawal, end stage renal disease/su [Surgery], end stage renal disease/th [Therapy], fever/co [Complication], gastroscopy, graft versus host reaction/dt [Drug Therapy], graft versus host reaction/pc [Prevention], Haemophilus parainfluenzae, hemolysis/di [Diagnosis], hemolysis/si [Side Effect], HLA matching, human, hypercholesterolemia, hypertension, hypotension/co [Complication], hypotension/dt [Drug Therapy], immunosuppressive treatment, intensive care, kidney biopsy, kidney cortex necrosis/di [Diagnosis], kidney pancreas transplantation, leg thrombosis/di [Diagnosis], leg thrombosis/dt [Drug Therapy], leukocyte count, low drug dose, male, medical history, middle aged, pancytopenia/si [Side Effect], paronychia/co [Complication], paronychia/dt [Drug Therapy], peritoneal dialysis, plasma exchange, Pseudomonas infection/co [Complication], Pseudomonas infection/dt [Drug Therapy], reflux esophagitis/di [Diagnosis], remission, review, sigmoidoscopy, thrombocyte count, thrombosis/dt [Drug Therapy], thrombosis/pc [Prevention], thrombosis prevention, thrombotic thrombocytopenic purpura/co [Complication], thrombotic thrombocytopenic purpura/di [Diagnosis], thrombotic thrombocytopenic purpura/dt [Drug Therapy], thrombotic thrombocytopenic purpura/th [Therapy], triacylglycerol lipase blood level, urinary tract infection/co [Complication], urinary tract infection/dt [Drug Therapy], vomiting/si [Side Effect], acetylsalicylic acid/dt [Drug Therapy], basiliximab/cb [Drug Combination], basiliximab/dt [Drug Therapy], beta2 glycoprotein 1/ec [Endogenous Compound], cardiolipin antibody/ec [Endogenous Compound], corticosteroid/cb [Drug Combination], corticosteroid/dt [Drug Therapy], creatinine/ec [Endogenous Compound], eculizumab/ae [Adverse Drug Reaction], eculizumab/dt [Drug Therapy], eculizumab/iv [Intravenous Drug Administration], enoxaparin/dt [Drug Therapy], everolimus/dt [Drug Therapy], flucloxacillin/dt [Drug Therapy], flucloxacillin/iv [Intravenous Drug Administration], HLA antibody/ec [Endogenous Compound], inotropic agent/dt [Drug Therapy], leukocyte antigen/ec [Endogenous Compound], mycophenolic acid/cb [Drug Combination], mycophenolic acid/dt [Drug Therapy], novel erythropoiesis stimulating protein/dt [Drug Therapy], phospholipid antibody/ec [Endogenous Compound], piperacillin plus tazobactam/dt [Drug Therapy], prednisolone/dt [Drug Therapy], tacrolimus/cb [Drug Combination], tacrolimus/dt [Drug Therapy], thymocyte antibody/dt [Drug Therapy], triacylglycerol lipase/ec [Endogenous Compound], warfarin/dt [Drug Therapy], catheter/am [Adverse Device Effect], human tissue, adult, anemia/di [Diagnosis], anemia/dt [Drug Therapy], antibody titer, bacterium identification, biochemical analysis, bone marrow biopsy, bone marrow suppression/di [Diagnosis], case report, catheter, creatinine blood level, deep vein thrombosis/di [Diagnosis], deep vein thrombosis/dt [Drug Therapy], diabetic retinopathy, diarrhea/co [Complication], diarrhea/si [Side Effect], Doppler flowmetry, drug dose increase, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39529Test
Nephrology
Click here for full text options
LibKey Link

مصطلحات الفهرس: drug dose reduction, drug substitution, drug withdrawal, end stage renal disease/su [Surgery], end stage renal disease/th [Therapy], fever/co [Complication], gastroscopy, graft versus host reaction/dt [Drug Therapy], graft versus host reaction/pc [Prevention], Haemophilus parainfluenzae, hemolysis/di [Diagnosis], hemolysis/si [Side Effect], HLA matching, human, hypercholesterolemia, hypertension, hypotension/co [Complication], hypotension/dt [Drug Therapy], immunosuppressive treatment, intensive care, kidney biopsy, kidney cortex necrosis/di [Diagnosis], kidney pancreas transplantation, leg thrombosis/di [Diagnosis], leg thrombosis/dt [Drug Therapy], leukocyte count, low drug dose, male, medical history, middle aged, pancytopenia/si [Side Effect], paronychia/co [Complication], paronychia/dt [Drug Therapy], peritoneal dialysis, plasma exchange, Pseudomonas infection/co [Complication], Pseudomonas infection/dt [Drug Therapy], reflux esophagitis/di [Diagnosis], remission, review, sigmoidoscopy, thrombocyte count, thrombosis/dt [Drug Therapy], thrombosis/pc [Prevention], thrombosis prevention, thrombotic thrombocytopenic purpura/co [Complication], thrombotic thrombocytopenic purpura/di [Diagnosis], thrombotic thrombocytopenic purpura/dt [Drug Therapy], thrombotic thrombocytopenic purpura/th [Therapy], triacylglycerol lipase blood level, urinary tract infection/co [Complication], urinary tract infection/dt [Drug Therapy], vomiting/si [Side Effect], acetylsalicylic acid/dt [Drug Therapy], basiliximab/cb [Drug Combination], basiliximab/dt [Drug Therapy], beta2 glycoprotein 1/ec [Endogenous Compound], cardiolipin antibody/ec [Endogenous Compound], corticosteroid/cb [Drug Combination], corticosteroid/dt [Drug Therapy], creatinine/ec [Endogenous Compound], eculizumab/ae [Adverse Drug Reaction], eculizumab/dt [Drug Therapy], eculizumab/iv [Intravenous Drug Administration], enoxaparin/dt [Drug Therapy], everolimus/dt [Drug Therapy], flucloxacillin/dt [Drug Therapy], flucloxacillin/iv [Intravenous Drug Administration], HLA antibody/ec [Endogenous Compound], inotropic agent/dt [Drug Therapy], leukocyte antigen/ec [Endogenous Compound], mycophenolic acid/cb [Drug Combination], mycophenolic acid/dt [Drug Therapy], novel erythropoiesis stimulating protein/dt [Drug Therapy], phospholipid antibody/ec [Endogenous Compound], piperacillin plus tazobactam/dt [Drug Therapy], prednisolone/dt [Drug Therapy], tacrolimus/cb [Drug Combination], tacrolimus/dt [Drug Therapy], thymocyte antibody/dt [Drug Therapy], triacylglycerol lipase/ec [Endogenous Compound], warfarin/dt [Drug Therapy], catheter/am [Adverse Device Effect], human tissue, adult, anemia/di [Diagnosis], anemia/dt [Drug Therapy], antibody titer, bacterium identification, biochemical analysis, bone marrow biopsy, bone marrow suppression/di [Diagnosis], case report, catheter, creatinine blood level, deep vein thrombosis/di [Diagnosis], deep vein thrombosis/dt [Drug Therapy], diabetic retinopathy, diarrhea/co [Complication], diarrhea/si [Side Effect], Doppler flowmetry, drug dose increase, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39529Test
Nephrology
Click here for full text options
LibKey Link

مصطلحات الفهرس: phase 4 clinical trial (topic), priority journal, protein targeting, randomized controlled trial (topic), T lymphocyte activation, abatacept/dt [Drug Therapy], adalimumab/dt [Drug Therapy], alemtuzumab/dt [Drug Therapy], atacicept/dt [Drug Therapy], basiliximab/dt [Drug Therapy], belatacept/dt [Drug Therapy], belimumab/dt [Drug Therapy], biological product/dt [Drug Therapy], blisibimod/dt [Drug Therapy], canakinumab/dt [Drug Therapy], certolizumab pegol/dt [Drug Therapy], efalizumab/dt [Drug Therapy], epratuzumab/dt [Drug Therapy], etanercept/dt [Drug Therapy], golimumab/dt [Drug Therapy], infliximab/dt [Drug Therapy], milatuzumab/dt [Drug Therapy], obinutuzumab/dt [Drug Therapy], ocrelizumab/dt [Drug Therapy], ofatumumab/dt [Drug Therapy], OKT 3/dt [Drug Therapy], recombinant interleukin 1 receptor blocking agent/dt [Drug Therapy], rituximab/dt [Drug Therapy], rontalizumab/dt [Drug Therapy], secukinumab/dt [Drug Therapy], sifalimumab/dt [Drug Therapy], sirukumab/dt [Drug Therapy], tocilizumab/dt [Drug Therapy], unindexed drug, veltuzumab/dt [Drug Therapy], membranous glomerulonephritis, ANCA associated vasculitis, article, autoimmune disease/dt [Drug Therapy], autoimmunity, B lymphocyte, human, humoral immunity, kidney disease/dt [Drug Therapy], lupus erythematosus nephritis, lymphocyte differentiation, nonhuman, phase 2 clinical trial (topic), phase 3 clinical trial (topic), Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39947Test
Nature Reviews Nephrology
Click here for full text options
LibKey Link

مصطلحات الفهرس: phase 4 clinical trial (topic), priority journal, protein targeting, randomized controlled trial (topic), T lymphocyte activation, abatacept/dt [Drug Therapy], adalimumab/dt [Drug Therapy], alemtuzumab/dt [Drug Therapy], atacicept/dt [Drug Therapy], basiliximab/dt [Drug Therapy], belatacept/dt [Drug Therapy], belimumab/dt [Drug Therapy], biological product/dt [Drug Therapy], blisibimod/dt [Drug Therapy], canakinumab/dt [Drug Therapy], certolizumab pegol/dt [Drug Therapy], efalizumab/dt [Drug Therapy], epratuzumab/dt [Drug Therapy], etanercept/dt [Drug Therapy], golimumab/dt [Drug Therapy], infliximab/dt [Drug Therapy], milatuzumab/dt [Drug Therapy], obinutuzumab/dt [Drug Therapy], ocrelizumab/dt [Drug Therapy], ofatumumab/dt [Drug Therapy], OKT 3/dt [Drug Therapy], recombinant interleukin 1 receptor blocking agent/dt [Drug Therapy], rituximab/dt [Drug Therapy], rontalizumab/dt [Drug Therapy], secukinumab/dt [Drug Therapy], sifalimumab/dt [Drug Therapy], sirukumab/dt [Drug Therapy], tocilizumab/dt [Drug Therapy], unindexed drug, veltuzumab/dt [Drug Therapy], membranous glomerulonephritis, ANCA associated vasculitis, article, autoimmune disease/dt [Drug Therapy], autoimmunity, B lymphocyte, human, humoral immunity, kidney disease/dt [Drug Therapy], lupus erythematosus nephritis, lymphocyte differentiation, nonhuman, phase 2 clinical trial (topic), phase 3 clinical trial (topic), Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39947Test
Nature Reviews Nephrology
LibKey Link

مصطلحات الفهرس: bipolar disorder/dt [Drug Therapy], case report, creatinine blood level, drug dose increase, drug withdrawal, end stage renal disease/co [Complication], end stage renal disease/th [Therapy], evening dosage, female, graft failure/co [Complication], graft recipient, graft rejection/co [Complication], graft rejection/dt [Drug Therapy], grandiose delusion, human, immunosuppressive treatment, kidney biopsy, kidney graft, kidney transplantation, low drug dose, maintenance therapy, mental health, middle aged, morning dosage, nephrotoxicity, plasmapheresis, postoperative complication/co [Complication], practice guideline, priority journal, psychosis/si [Side Effect], review, alemtuzumab/dt [Drug Therapy], basiliximab/dt [Drug Therapy], haloperidol/cb [Drug Combination], haloperidol/dt [Drug Therapy], HLA antigen, immunoglobulin/iv [Intravenous Drug Administration], immunosuppressive agent, methylprednisolone/dt [Drug Therapy], methylprednisolone/iv [Intravenous Drug Administration], mycophenolic acid 2 morpholinoethyl ester/dt [Drug Therapy], prednisolone/dt [Drug Therapy], prednisolone/pa [Parenteral Drug Administration], rapamycin, tacrolimus/ae [Adverse Drug Reaction], kidney function, benzatropine/cb [Drug Combination], benzatropine/dt [Drug Therapy], carbamazepine/cb [Drug Combination], carbamazepine/dt [Drug Therapy], clonazepam/cb [Drug Combination], clonazepam/dt [Drug Therapy], creatinine/ec [Endogenous Compound], cyclosporin/dt [Drug Therapy], cytochrome P450, everolimus/dt [Drug Therapy], everolimus/pa [Parenteral Drug Administration], acute psychosis, adult, antibody mediated rejection, auditory hallucination, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/40796Test
Nephrology
Click here for full text options
LibKey Link